• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗HLA - DR及其他HLA抗原的抗血清对淋巴母细胞系增殖的抑制作用。

Suppression of lymphoblastoid cell line proliferation by antisera to HLA-DR and other HLA antigens.

作者信息

Gatti R A, Cousineau M, Naeim F, Leibold W

出版信息

Tissue Antigens. 1979 Sep;14(3):213-22. doi: 10.1111/j.1399-0039.1979.tb00843.x.

DOI:10.1111/j.1399-0039.1979.tb00843.x
PMID:316587
Abstract

We have observed that certain antisera to HLA antigens suppress the in vitro proliferation of lymphoblastoid cell lines. An antiserum to HLA-B8 demonstrated suppressor activity associated with the presence of B8 antigen on the target LCLs; this activity was removed by absorption with platelets or with B8-positive LCLs. An antiserum to HLA-DRw7 suppressed proliferation of all six DRw7-positive LCLs and none of 12 DRw7-negative LCLs; this activity was removed by absorptions with three DRw7-positive LCLs, each representing a different HLA-D allele (i.e. Dw7, 10 and 11); it could not be removed by triple serial absorptions with platelets from multiple-donor pools. These experiments indicate that the suppressor activity of this serum is specifically associated with antibodies to DRw7. Our model of LCL growth suppression by HLA antisera is easily manipulated and provides a definitive tool for further characterizing HLA antigens and antisera in a complement-independent system.

摘要

我们观察到,某些针对HLA抗原的抗血清可抑制淋巴母细胞系的体外增殖。一种针对HLA - B8的抗血清表现出与靶LCL上存在B8抗原相关的抑制活性;这种活性可通过用血小板或B8阳性LCL吸收而去除。一种针对HLA - DRw7的抗血清抑制了所有六种DRw7阳性LCL的增殖,而对12种DRw7阴性LCL均无抑制作用;这种活性可通过用三种DRw7阳性LCL吸收而去除,每种LCL代表不同的HLA - D等位基因(即Dw7、10和11);用来自多个供体库的血小板进行三次连续吸收不能去除这种活性。这些实验表明,该血清的抑制活性与针对DRw7的抗体特异性相关。我们的HLA抗血清抑制LCL生长的模型易于操作,并为在非补体依赖系统中进一步鉴定HLA抗原和抗血清提供了一个决定性工具。

相似文献

1
Suppression of lymphoblastoid cell line proliferation by antisera to HLA-DR and other HLA antigens.抗HLA - DR及其他HLA抗原的抗血清对淋巴母细胞系增殖的抑制作用。
Tissue Antigens. 1979 Sep;14(3):213-22. doi: 10.1111/j.1399-0039.1979.tb00843.x.
2
Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.针对 HLA-B12 特异性的异基因抗淋巴母细胞系血清的血清学分析。
Immunogenetics. 1980;10(6):595-602. doi: 10.1007/BF01572593.
3
Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera.针对单核细胞和B淋巴细胞中表达的HLA - D区产物的细胞介导细胞毒性。I. 未标记细胞的阻断作用和抗血清的抑制作用。
Immunogenetics. 1980;10(1):31-8. doi: 10.1007/BF01561550.
4
[The search for anti-B cell antibodies and HLA-DR typing in Montpellier].[在蒙彼利埃进行的抗B细胞抗体检测及HLA-DR分型研究]
Rev Fr Transfus Immunohematol. 1980 Sep;23(4):411-25. doi: 10.1016/s0338-4535(80)80167-x.
5
Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.淋巴母细胞系和上皮细胞系上HLA抗原的检测以及HLA-Cw5和HLA-Cw8的交叉反应性
Hum Immunol. 1983 Mar;6(3):119-31. doi: 10.1016/0198-8859(83)90096-4.
6
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.伯基特淋巴瘤细胞系中I类人白细胞抗原及爱泼斯坦-巴尔病毒编码的潜伏膜蛋白的下调。
Proc Natl Acad Sci U S A. 1987 Jul;84(13):4567-71. doi: 10.1073/pnas.84.13.4567.
7
Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.胎牛血清特异性T4阳性细胞毒性T淋巴细胞克隆对肿瘤来源及体外爱泼斯坦-巴尔病毒转化的B细胞系的差异识别
Cell Immunol. 1986 Apr 1;98(2):453-66. doi: 10.1016/0008-8749(86)90304-7.
8
Heterologous B-cell antisera may detect non-Ig, non-HLA-DR antigens.异种B细胞抗血清可能检测到非免疫球蛋白、非HLA - DR抗原。
Scand J Immunol. 1979;10(1):17-24. doi: 10.1111/j.1365-3083.1979.tb01329.x.
9
HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.采用 maxi-EBV 系统建立的 B 淋巴母细胞系中 WT1 肿瘤抗原的 HLA 限制性呈递。
Cancer Gene Ther. 2012 Aug;19(8):566-71. doi: 10.1038/cgt.2012.34. Epub 2012 Jun 22.
10
Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.利用血小板和淋巴母细胞系简化梅里特系统的B细胞抗血清
Transplant Proc. 1977 Mar;9(1):439-44.